Bogart Wealth LLC’s Lipocine LPCN Stock Holding History

Bogart Wealth LLC’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8	Hold	3	–	–	﹤0.01%	1996
2026 Q1	$24	Buy	+3	New	+$26	﹤0.01%	1792

Other funds holding LPCN

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bogart Wealth LLC's LPCN Position: Q2 2026 in Review

Bogart Wealth LLC held its Lipocine (LPCN) position steady in Q2 2026 at 3 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Bogart Wealth LLC first reported a position in LPCN in Q1 2026 and has held it in 2 quarters since. The position peaked at $24 in Q1 2026. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

Bogart Wealth LLC held 3 shares of Lipocine worth $8 as of Q2 2026.
Bogart Wealth LLC left its Lipocine share count unchanged in Q2 2026.
Lipocine made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1996 holding.
Bogart Wealth LLC first reported a position in Lipocine in Q1 2026 and has held it in 2 quarters since.
Bogart Wealth LLC's Lipocine position peaked at $24 in Q1 2026.
36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.